Predictors of Clinical Response to Intravenous Secukinumab Among Patients with PsA: A Post Hoc Analysis of a Phase 3 Trial

被引：0
|
作者：
Kivitz, Alan [1 ]
Sedova, Liliana [2 ,3 ]
Churchill, Melvin [4 ]
Vizcaya, Cynthia [5 ]
Sutariya, Reema [6 ]
Cao, Wenhao [6 ]
Singhal, Atul [7 ]
机构：
[1] Altoona Ctr Clin Res, Duncansville, PA USA
[2] Inst Rheumatol, Prague, Czech Republic
[3] Charles Univ Prague, Clin Rheumatol, Fac Med 1, Prague, Czech Republic
[4] Arthrit Ctr Nebraska, Lincoln, NE USA
[5] Novartis Pharma AG, Basel, Switzerland
[6] Novartis Pharmaceut, E Hanover, NJ USA
[7] Southwest Arthrit Res Grp, Mesquite, TX USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2354
引用
收藏
页码：4750 / 4752
页数：3
相关论文
共 50 条
  • [1] Predictors of Clinical Response to Intravenous Secukinumab Among Patients with Axial Spondyloarthritis: A Post Hoc Analysis of a Phase 3 Trial
    Deodhar, Atul
    Dokoupilova, Eva
    Vizcaya, Cynthia
    Sutariya, Reema
    Bao, Weibin
    Kapur, Karen
    Rohrer, Susanne
    Kivitz, Alan
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3020 - 3023
  • [2] Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial
    Baraliakos, Xenofon
    Pournara, Effie
    Gossec, Laure
    Mease, Philip J.
    White, Roisin
    O'Brien, Eamonn
    Schulz, Barbara
    Marzo-Ortega, Helena
    Coates, Laura C.
    RMD OPEN, 2022, 8 (02):
  • [3] Baseline Predictors of Clinical Response: A Post Hoc Analysis of the Ambition Trial
    Benza, Raymond
    Blair, Christiana
    Patel, Krishna
    Eads, Michael
    CHEST, 2017, 152 (04) : 1052A - 1052A
  • [4] Time to Clinical Response to Secukinumab Across Disease Domains Among Patients with Psoriatic Arthritis: A Pooled Post Hoc Analysis of 4 Phase 3 Trials
    Coates, Laura
    McInnes, Iain
    Husni, M. Elaine
    Vizcaya, Cynthia
    Bao, Weibin
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1200 - 1203
  • [5] Secukinumab in the Treatment of Dactylitis in Patients with Psoriatic Arthritis: Post Hoc Analysis Results from a Randomized Phase 3 Trial
    Kirkham, Bruce
    Nash, Peter
    Navarra, Sandra
    Quebe-Fehling, Erhard
    Gaillez, Corine
    Sastre, Carlos
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [6] Predictors of Nail Response with Guselkumab: A Post Hoc Analysis of the VOYAGE 2 Clinical Trial
    Egeberg, Alexander
    Tillett, William
    Sonkoly, Eniko
    Gorecki, Patricia
    Tjarnlund, Anna
    Buyze, Jozefien
    Wegner, Sven
    McGonagle, Dennis
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2008 - 2011
  • [7] Intravenous fluids for migraine: a post hoc analysis of clinical trial data
    Balbin, Jerome Edward B.
    Nerenberg, Rebecca
    Baratloo, Alireza
    Friedman, Benjamin W.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2016, 34 (04): : 713 - 716
  • [8] Predictors of outcome in large vessel occlusion stroke patients with intravenous tirofiban treatment: a post hoc analysis of the RESCUE BT clinical trial
    Liu, Xiang
    He, Wencheng
    Li, Meiqiong
    Yang, Jie
    Huang, Jiacheng
    Kong, Weilin
    Guo, Changwei
    Hu, Jinrong
    Liu, Shuai
    Yang, Dahong
    Song, Jiaxing
    Peng, Zhouzhou
    Li, Linyu
    Tian, Yan
    Zi, Wenjie
    Yue, Chengsong
    Li, Fengli
    BMC NEUROLOGY, 2024, 24 (01)
  • [9] Impact of Uric Acid Levels on Clinical and Radiographic Characteristics in Psoriatic Arthritis and Response to Secukinumab: A Pooled "Post Hoc" Analysis from Five Phase 3 Studies
    Felten, Renaud
    Widawski, Laura
    Spielmann, Lionel
    Gaillez, Corine
    Bao, Weibin
    O'Neill, Hugh
    Gottenberg, Jacques-Eric
    Duret, Pierre-Marie
    Messer, Laurent
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1988 - 1991
  • [10] Predictors of response to pharmacotherapy in children and adolescents with psychiatric disorders: A combined post hoc analysis of four clinical trial data
    Tsujii, Takashi
    Sakurai, Hitoshi
    Takeuchi, Hiroyoshi
    Suzuki, Takefumi
    Mimura, Masaru
    Uchida, Hiroyuki
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2022, 42 (04) : 516 - 520
12345